William Blair Forecasts Strong Biotech Recovery to Persist Through 2026

Chicago, Friday, 12 December 2025.
After a nearly 75% index surge since April, analysts project the biotech sector will outperform recent bear markets in 2026, contingent on favorable clinical data and regulatory stability.